Pimecrolimus

Used for the treatment of mild to moderate atopic dermatitis (eczema), particularly when corticosteroids are unsuitable.

Burning, itching, redness at application site; rare risk of systemic immunosuppression or infection.

Avoid long-term continuous use; minimize sun exposure; not for use in immunocompromised patients.

Hypersensitivity to pimecrolimus or any component of the formulation.

Apply a thin layer to affected area twice daily; avoid occlusive dressings.

Exported to Brazil, Mexico, Colombia, Chile, Venezuela, Ecuador, Bolivia, Dominican Republic, Guatemala, Panama, Guyana, Trinidad & Tobago, El Salvador

Topical cream (1%).